Related Experiment Video
Updated: Oct 11, 2025

12:05
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
11.9K
Abnormal monocyte differentiation and function in chronic myelomonocytic leukemia
1Moffitt Cancer Center, Department of Malignant Hematology, Tampa, Florida, USA.
Current Opinion in Hematology
|December 2, 2021
Summary
This review explores monocyte development and function, contrasting normal states with chronic myelomonocytic leukemia (CMML). It highlights novel markers and therapeutic targets for CMML monocytes.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Monocytes are crucial for immune surveillance and host defense.
- Their development and function are well-understood in steady-state hematopoiesis.
- However, their role in myeloid malignancies remains less explored.
Purpose of the Study:
- To review monocyte development, function, and regulation during steady-state hematopoiesis.
- To contrast these with aberrations in myelomonocytic leukemias, particularly chronic myelomonocytic leukemia (CMML).
- To highlight novel markers, signaling pathways, and therapeutic strategies for CMML.
Main Methods:
- Literature review of major studies on monocyte biology and CMML.
- Analysis of findings on monocyte characterization, signaling, and disease roles.
Main Results:
- Identified novel markers for CMML monocytes.
- Described altered signaling cascades and roles in disease progression.
- Discussed potential therapeutic interventions targeting monocyte-mediated inflammation.
Conclusions:
- Monocyte secretome alterations in CMML present unique challenges.
- Therapeutic strategies targeting leukemic initiating cells and malignant monocytes are promising.
- Disrupting the malignant monocyte axis offers a rationale for novel treatments.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
3.4K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.4K
Disorders of Leukocytes
1.2K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.2K

